2025-05-15T16:29:23-05:00 2024-06-30 363321958 Desmond & Ahern Ltd 10827 S Western Avenue Chicago IL 60643 990 2023-07-01 366009467 Orthopaedic Research and Education Foundation ORTH 8476989980 9400 W Higgins Road 320 Rosemont IL 60018 Andrew N Pollak MD Treasurer 8476989980 2025-05-15 1 1 Mel Padillo P03172019 7737794720 2025-04-08 2023 2025-03-06 01:10:19Z OREF Andrew N Pollak MD 9400 W Higgins Road 320 Rosemont IL 60018 13546245 0 X www.oref.org X 1955 IL Improving lives by supporting excellence in orthopaedic research. 17 17 14 101 0 0 3219832 3251613 0 0 422121 1004153 0 0 3641953 4255766 2130495 1321355 0 0 2146586 2285758 0 0 867213 1297077 1631072 5574158 5238185 -1932205 -982419 22252031 21495900 4921101 4459455 17330930 17036445 The Orthopaedic Research and Education Foundation (OREF) mission is improving lives by supporting excellence in orthopaedic research. OREF's vision is that it will be the leader in supporting orthopaedic research to improve function, eliminate pain and restore mobility. 0 0 3846993 1321355 Grant program: The purpose of OREF is to support research into the causes and treatment of musculoskeletal diseases and injuries. OREF's niche is supporting surgeon-researchers and PHD-researchers in basic science/translation, clinical, and health services research. OREF's education program offers new orthopaedic medical researchers the opportunity to develop their research interests and skills. Through educational programming, OREF supports emerging talent to help them successfully pursue research careers. 3846993 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 12 0 1 14 1 0 0 0 0 0 0 0 0 0 0 0 0 X 17 17 0 0 1 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AR AZ CA CT DC DE FL GA IL IN KS KY LA MA MD ME MI MS MN MO MT NC ND NE NH NM NY OH OK OR PA RI SC SD TN UT VA WA WI WV WY X X Rhonda Dirr and Lee Grossman 8476989980 9400 W Higgins Road Rosemont IL 60018 Joshua J Jacobs MD President 5.00 X X 0 0 0 Thomas P Sculco MD Past President 5.00 X X 0 0 0 Richard F Kyle MD Past President 5.00 X X 0 0 0 Andrew N Pollak MD Secretary/Treasurer 5.00 X X 0 0 0 Francis Y Lee MD PhD Chair RGC 5.00 X X 0 0 0 Jeffrey S Abrams MD Chair, Innovations & Partn 5.00 X X 0 0 0 Richard F Santore MD Chair-Individual Developme 5.00 X X 0 0 0 Annunziato Amendola MD Trustee 5.00 X 0 0 0 Daniel J Berry MD Trustee 5.00 X 0 0 0 David C Templeman MD Trustee 5.00 X 0 0 0 Eric V Dremel Trustee 5.00 X 0 0 0 Evalina Burger-Van der Walt MD Trustee 5.00 X 0 0 0 James R Ficke MD Trustee 5.00 X 0 0 0 Jeremie M Axe MD Trustee 5.00 X 0 0 0 John D Kelly IV MD Trustee 5.00 X 0 0 0 Karen L Hackett Trustee 5.00 X 0 0 0 Mary Lloyd Ireland MD Trustee 5.00 X 0 0 0 Michael M Chau MD PhD Trustee 5.00 X 0 0 0 Michael P Bolognesi MD Trustee 5.00 X 0 0 0 Nicholas M Bernthal MD Trustee 5.00 X 0 0 0 Stuart Weinstein MD Trustee 5.00 X 0 0 0 Rhonda Dirr Executive Director 40.00 X 104098 0 22993 Lee Grossman CEO 40.00 X 269749 0 59039 Dan Krupp Corporate Relations/Innova 40.00 X 146351 0 13450 Deborah Cummins VP of Research and Grants 40.00 X 127342 0 37335 Edward Hoover Senior VP of Development 40.00 X 121133 0 56841 Karen Pubentz Sr. Director of Communicat 40.00 X 131867 0 25415 John Johnson Campaigns Director 1.00 X 105943 0 12206 1006483 0 227279 7 0 1 0 Blue Cross Blue Shield of IL PO Box 650615 Dallas TX 75265 Health Insurance 260561 1 3251613 3251613 354395 354395 9940237 9290479 649758 649758 649758 4255766 0 0 1004153 1133161 1133161 188194 188194 455879 286311 67664 101904 1403186 881261 208266 313659 226807 142444 33664 50699 75674 47526 11232 16916 124212 78010 18436 27766 22474 12449 5594 4431 48130 26661 11980 9489 36479 36479 117910 65315 29348 23247 209517 114762 6668 88087 57485 34412 14021 9052 169469 106434 25153 37882 157948 33289 31491 93168 36211 21460 3889 10862 176814 107290 69524 9983 6270 1481 2232 76836 64785 4809 7242 Ortho Partners Awards 494000 494000 Bad debt 13000 13000 Dues and subscriptions 4711 2959 699 1053 Miscellaneous 105 105 5238185 3846993 523979 867213 232 77117 2510564 361086 1487666 624017 54606 75808 181754 177594 14143 4160 13343812 15624036 4841008 4729676 22252031 21495900 514904 426555 3560624 3384500 845573 648400 4921101 4459455 X -1667970 -3363287 18998900 20399732 17330930 17036445 22252031 21495900 X -982419 671694 16240 X X 0 1 X 1 0 X 3932349 2959720 3690278 3219832 3251613 17053792 3932349 2959720 3690278 3219832 3251613 17053792 1647600 15406192 467531 389234 544505 324472 53072 1778814 18832606 0.81810 0.80300 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 X 11255229 605845 1396608 -394833 12862845 10561394 44291 1160278 510734 11255229 13241439 6579 -2143996 542628 10561394 10199908 7026 3592759 558254 13241439 7961755 13785 -82175 19900 7873465 0 0 50447 48925 1522 131307 128669 2638 4160 Charitable Remainder Trust Receivable 2742892 Cash Surrender Value of Life Insurance 1906949 Other receivables 12584 Right Of Use - Lease Assets 67251 4729676 Due to Orthopaedic Partners 580380 Lease Liability ST 68020 648400 X 4923109 671694 32128 703822 4219287 36479 36479 4255766 5217594 15888 15888 5201706 36479 36479 5238185 Part IV, Line 2b: On behalf of other orthopaedic organizations, the Foundation accepts contributions for which it performs recordkeeping and provides grants requested by those organizations. Part X, Line 2: FIN 48 Note from Audited Financial Statements: The Foundation, an Illinois nonprofit corporation, is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code and applicable state law, except for taxes pertaining to unrelated business income, if any. The Foundation's annual information and income tax returns filed with the federal and state governments are subject to examination generally for three years after they are filed. The Foundation has adopted the requirements for accounting for uncertain tax positions and management has determined that the Foundation was not required to record a liability related to uncertain tax positions as of June 30, 2024. Part XI, Line 2d - Other Adjustments: Change in cash surrender value of life insurance policies 44,641. Change in charitable remainder trust receivable -12,513. Part XII, Line 2d - Other Adjustments: Orthopaedic partner endowment distribution 15,888. 1 Boston Children's Hospital 300 Longwood Avenue Boston MA 02115 042774441 20000 0 Effect of vitamin D in prevention and treatment of pediatric fractures Columbia University Irving Medical Center Sponsored Projects Administration Columbia University 630 West 168th New York NY 10032 135598093 20000 0 Enhanced Enthesis Regeneration via Gli1+ Enthesis Stem Cell Treatment MAYO CLINIC ROCHESTER MN 200 First St SW Rochester MN 559050001 416011702 20000 0 Osteoarthritis Gene Therapy: A 30-Year Journey from Concept to Clinical Trials Medical Technology Enterprise Consortium - The Geneva Foundation 315 Sigma Drive Summerville SC 29486 474960128 50000 0 Objective Dynamic and 3D Knee Assessment Medical Device to Improve Recovery and Accelerate Return to Readiness of Members with Knee Pain Medical Technology Enterprise Consortium - The Henry Jackson Foundation for 315 Sigma Drive Summerville SC 29486 474960128 50000 0 Dynamic Gait-Synchronous Neuromuscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction MedStar Health Research Institute 6525 Belcrest Road Suite 700 Hyattsville MD 20782 526056274 149948 0 Treating Cauda Equina Syndrome from a Health Care Disparities Perspective The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 300000 0 Objective TKA Laxity: Correlation with Patient Perceptions of Instability? The Hospital for Special Surgery 535 East 70th Street New York NY 10021 131624135 50000 0 Characterizing the effects of corticosteroids in rotator cuff tendinopathy The Ohio State University 1960 Kenny Road Columbus OH 43210 316025986 20000 0 Transformative Solutions for Reducing Frequent 911 Fall Calls The Regents of the University of California on Behalf of its Davis Campus Office of Sponsored Programs One Shields Ave Davis CA 95616 946036494 50000 0 Decellularized Skeletal Muscle Matrix for Open Fractures with Muscle Loss The Trustees of the University of Pennsylvania 3451 Walnut Street Franklin Building 5th floor Philadelphia PA 19104 231352685 18290 0 Validating the use of Next-Generation Sequencing in Open Fracture Care University of Florida 207 Grinter Hall Gainesville FL 32611 596002052 25000 0 Educational tools for injury prevention guidelines for baseball caregivers University of Washington Office of Sponsored Programs 4333 Brooklyn Ave NE Box 359472 Seattle WA 98195 916001537 100000 0 Magnetic Microgels for Composite Musculoskeletal Tissue Regeneration Washington University in StLouis Campus Box 1054 One Brookings Drive St Louis MO 631304862 430653611 20000 0 Identification & Imaging of Skeletal Muscle Response to Graded Nerve Crush Washington University School of Medicine in St Louis 660 S Euclid Avenue Campus Box 8233 Saint Louis MO 63110 430653611 20000 0 Mediators of the OA Cascade in the Pre-Arthritic Hip Yale University PO Box 208327 New Haven CT 065208327 060646973 19980 0 Mid-Substance PCL Tear: A Novel Arthroscopic Direct Repair Technique London Health Sciences Centre Research Inc 750 Base Line Road Suite 300 Ontario Ontario CA 444444444 149943 0 Fixation for Fractures Around the Ankle in the Frail or Compromised Elderly Awards/Grants 7 10500 Resident Symposia 9 103000 Awards 17 74694 Part I, Line 2: The Research Grants Committee is responsible for allocating research funding to advance research in the specialty of orthopaedics and is empowered to establish criteria for the allocation and distribution of philanthropic funds to advance research in the specialty of orthopaedics, implement and conduct independent peer review process to select research funding recipients, prepare and distribute necessary promotional information and application forms for research grants and awards and to accept and allocate or decline to allocate, at its sole and absolute discretion, grants and awards for research. One-year grant recipients receive 50% of the funds to start, then 40% after a six-month financial report is received. A final scientific and lay report within 60 days after the grant ends along with a final financial report is required. Once OREF has the final reports the remaining 10% of the funds are released. One-time award/educational grant/lectureship grants receive full payment after they are approved. Documentation is in the file for lectureships, educational programs and awards. Two or three-year grants are paid and spread over the term of the grant. 10% is withheld until all of the reports are received. Multi-year grant recipients submit annual scientific reports which are then reviewed by the original peer review committee member. X X 0 0 0 0 0 0 0 0 0 Lee Grossman CEO 269749 0 0 0 0 0 25014 0 34025 0 328788 0 0 0 Edward Hoover Senior VP of Development 121133 0 0 0 0 0 11939 0 44902 0 177974 0 0 0 Deborah Cummins VP of Research and Grants 127342 0 0 0 0 0 5552 0 31783 0 164677 0 0 0 Dan Krupp Corporate Relations/Innova 146351 0 0 0 0 0 8060 0 5390 0 159801 0 0 0 Karen Pubentz Sr. Director of Communicat 131867 0 0 0 0 0 6935 0 18480 0 157282 0 0 0 Form 990, Part VI, Section A, line 4 Bylaws have been updated with revisions to the pages below. **** (new page 1, old page 1) Article II is now Purpose instead of Goals and Objectives with updated language. **** (new page 2, old page 2) Article VI, Section 3 The makeup of the board of trustees. **** (new page 3, old page 4) Section 10 of the old Offices and Places of Meeting is deleted. **** (new page 4, old page 5) Section 15 (old) is removed **** (new page 5, old page 6) Article V, Section 1, A, B & C are all revamped. **** (new page 5, old page 7) Section 2 They created a 2nd President-Elect **** (old page 9) Section 2 is removed. Form 990, Part VI, Section B, line 11b The Finance Committee reviewed and approved the Form 990. It was provided to the Board of Directors, who had an opportunity to review the return prior to filing. Form 990, Part VI, Section B, line 12c All Trustees annual conflict of interest statements are on file with the OREF CEO. The CEO reviews meeting agendas prior to the meeting and notifies leadership of any issues that need to be addressed before the discussions take place. Any individual who gives notice of a potential conflict is to abstain from participation in discussions related to that item. Form 990, Part VI, Section B, line 15 The Foundation has a formal process to determine the compensation of its CEO. The process includes the following: 1) Review and approval by the Board of Trustees or Compensation Committee; 2) Use of comparable compensation data; 3) Contemporaneous documentation and record keepping. Form 990, Part VI, Section C, line 19 The Foundation made its governing documents, conflict of interest policy, and financial statements available to the public upon request for the period of disclosure set forth in IRC Section 6104(d). Form 990, Part XI, line 9: Orthopaedic partner endowment distribution -15,888. Change in cash surrender value of life insurance policies 44,641. Change in charitable remainder trust receivable -12,513. Form 990, Part XII, line 2c: The process has not changed from the prior year. Charitable Remainder Trusts Charitable trusts IL T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0